Zimmer Biomet Announces Second Quarter 2026 Financial Results
Second quarter net sales of $2.177 billion increased 4.8% on a reported basis, 4.7% on a constant currency1 basis and 4.0% on an organic constant currency1 basis Second quarter diluted earnings per share were $1.03, an increase of 33.8%; adjusted1 diluted earnings per share were $2.07,...
Covered in this story
What has happened since
- Zimmer Biomet is down 2.5% since this was published, 76 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $ZBH yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Zimmer Biomet →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.